In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating in ...
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today ...